Durability of neda-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: Clarity extension

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 62b4113bfec91dff49853b8175341dbb9b0d5ded
First added on: Feb 11, 2025